3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Fallopian Tube Neoplasms
28
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
22
Triple Negative Breast Neoplasms
15
Pancreatic Neoplasms
13
Breast Neoplasms, Male
11
Lung Neoplasms
10
Brenner Tumor
10
Inflammatory Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Endometrial Adenocarcinoma
5
Adenocarcinoma of Lung
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Melanoma
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma, Bronchiolo-Alveolar
4
Adenocarcinoma Of Esophagus
4
Pleural Effusion, Malignant
3
Pancreatic Adenocarcinoma
3
Neoplasms
3
Thymoma
2
Neurotoxicity Syndromes
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinosarcoma
2
Breast Carcinoma In Situ
2
Interventions
Paclitaxel
6
Carboplatin
6
Gemcitabine
3
pembrolizumab
2
Irinotecan
2
Erlotinib Hydrochloride
2
Capecitabine
2
Bevacizumab
2
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
etoposide phosphate
1
erythromycin propionate-N-acetylcysteinate
1
entrectinib
1
cobimetinib
1
belinostat
1
atezolizumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
alectinib
1
Vemurafenib
1
Surveys and Questionnaires
1
Oxaliplatin
1
HhAntag691
1
Everolimus
1
Etoposide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Unknown Primary
×
Taxes
×
Clear all
No trials found.